
Congressman Louie Gohmert (R-Texas) spoke to a Food and Drug Administration (FDA) committee on Wednesday to voice his concern about inserting the new mRNA “vaccine” technology into the bodies of America’s youth.
The group Congressman Gohmert spoke to was the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).
“There are many unanswered questions regarding the safety and efficacy of Covid vaccines, especially for babies and young children. I’m deeply concerned that the push to vaccinate these children is nothing more than a dystopian experiment with unknown consequences,” Gohmert told the FDA.
“These questions are critical and deserve thorough answers by FDA and VRBPAC prior to any Emergency Use Authorization (EUA) with the accompanied protection from liability for all harm done,” the congressman continued.
“In conclusion, some of us have grave concerns that in balancing the risks to rewards here, all the risk is on the children and all the billions of dollars of rewards go to the government-protected pharmaceuticals, leaving me to wonder if Republicans get a majority – I may need to have a bill and I’m working on it now – to allow civil and criminal liability to vaccine providers and accessories despite an EUA, which should force more sensitivity to vaccine harm to our young children. We’ve got to care more about our children.”
Last week, Gohmert and 17 other politicians sent a letter to VRBPAC containing a list of questions regarding the experimental jabs.
A few of the questions the congressman asked the FDA are listed below:
- Why has the FDA refused to release the hundreds of thousands of pages of data from pre-approval manufacturer studies, post-approval adverse events data, and other post-approval manufacturer data?
- What is the cardiac risk factor in administering these COVID vaccines to children?
- Is it possible that the proposed COVID vaccines in young children could create increased risk from future novel COVID variants?
The Centers for Disease Control and Prevention will hold meetings on Friday and Saturday to vote on Covid vaccine approval for kids under five years old.
If the measure passes and CDC Director Rochelle Walensky signs it, the Biden administration will begin shipping doses immediately.